Eastern Europe Western Europe Middle East Africa South America Australia Asia Central America North America
All India
WHO-GMP
Product Description
Details
Citicoline is used for Alzheimer's disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson's disease, attention deficit-hyperactive disorder (ADHD), and glaucoma.
Citicoline was originally developed in Japan for stroke.
It was later introduced as a prescription drug in many European countries.
In these countries it is now frequently prescribed for thinking problems related to circulation problems in the brain.
Citicoline seems to increase a brain chemical called phosphatidylcholine.
This brain chemical is important for brain function.
Citicoline might also decrease brain tissue damage when the brain is injured.